B₂ Agonists and Their Safety in the Treatment of Asthma

ISSN： 1539-6304

Source： Allergy and Asthma Proceedings, Vol.16, Iss.5, 1995-09, pp. : 235-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

β₂-Agonists and exercise-induced asthma

By Anderson Sandra Caillaud Corinne Brannan John

Clinical Reviews in Allergy and Immunology, Vol. 31, Iss. 2-3, 2006-06 ,pp. : 163-180

Humana Press, Inc

Access to resources Recommend Favorite

β₂-Agonists for asthma: The pediatric perspective

By Subbarao Padmaja Ratjen Felix

Clinical Reviews in Allergy and Immunology, Vol. 31, Iss. 2-3, 2006-06 ,pp. : 209-218

Humana Press, Inc

Access to resources Recommend Favorite

The safety profile of ciclesonide in the treatment of persistent asthma

By Craig Timothy

Allergy and Asthma Proceedings, Vol. 30, Iss. 3, 2009-05 ,pp. : 315-324

OceanSide Publications, Inc

Access to resources Recommend Favorite

Clinical concerns with inhaled β₂-agonists: Adult asthma

By Cockcroft D.

Clinical Reviews in Allergy and Immunology, Vol. 31, Iss. 2-3, 2006-06 ,pp. : 197-207

Humana Press, Inc

Access to resources Recommend Favorite

Beta Agonists in the Management of Asthma

By Dwyer John M.

Allergy and Asthma Proceedings, Vol. 4, Iss. 3, 1983-0 ,pp. : 195-200

OceanSide Publications, Inc

Access to resources Recommend Favorite